Sign In
Get Clay Free →

Suggestions

    Carolina Haefliger

    Head Translational Medicine at Debiopharm

    Professional Background

    Carolina Haefliger is a distinguished expert in clinical genetics and a prominent figure in the field of epigenetics. With a robust educational background and a diverse professional trajectory, she has significantly contributed to the fields of oncology, cardiovascular health, metabolism, and renal diseases through her work with leading pharmaceutical and biotech organizations. Carolina has a passion for advancing personalized healthcare, utilizing her expertise in translational biomarkers to enhance patient outcomes and tailor medicine to individual genetic profiles.

    Over the course of her career, Carolina has held a series of prestigious positions that exemplify her leadership and innovation in translational medicine. As the former Head of Translational Medicine at Debiopharm, she leveraged her skills to drive research initiatives that bridge the gap between laboratory discoveries and clinical applications. Her tenure at AstraZeneca as VP and head of the Centre for Genomics Research highlights her pivotal role in establishing and overseeing genomic projects aimed at understanding and treating diseases at the genetic level. Here, she made significant contributions to the Companion Diagnostics Unit focusing on cardiovascular and metabolic disorders, proving her versatility in handling various disease areas.

    Carolina's journey through the pharmaceutical industry continued at Novartis, where she excelled as a Senior Translational Medicine Strategic Planner. In this pivotal role, she orchestrated strategies that harnessed the power of biomarkers to inform drug development and regulatory strategies. Her experience at Roche Pharmaceuticals as a Senior Biomarker and Experimental Medicine Leader further solidified her reputation; her leadership here transformed experimental approaches to biomarker applications within clinical settings.

    Her role as Medical Director of Clinical Solutions at Epigenomics AG allowed her to strategize and implement solutions that address clinical needs with innovative epigenetic approaches. Her influence extends beyond her direct roles, as she continuously engages in academic collaborations that foster knowledge sharing and advance the field of personalized healthcare.

    Education and Achievements

    Education played a crucial role in shaping Carolina's career. She earned her Medical Degree (MD) from Universidad del Salvador, a prestigious institution known for its commitment to excellence in medical education. Carolina's academic background equipped her with a strong foundation in clinical sciences, paving the way for her future endeavors in translational medicine and genetic research.

    Throughout her career, Carolina has been a prominent advocate for the application of biomarkers in clinical settings, emphasizing their importance in the development of personalized medicine. Her specialties in clinical genetics, epigenetics, and experimental medicine studies reflect her commitment to advancing diagnostic and therapeutic approaches that consider the unique genetic landscape of each patient. Carolina’s work in these areas has led to advancements in understanding disease mechanisms and improving treatment strategies across various medical conditions, including cancer.

    Achievements

    • Leadership in Translational Medicine: As the Head of Translational Medicine at Debiopharm, Carolina led initiatives that successfully translated scientific discoveries into actionable clinical strategies, significantly impacting how treatments are developed and personalized.
    • Genomics Research at AstraZeneca: During her time as VP Head at AstraZeneca, she enhanced the research environment focused on genomic advancements, fostering collaboration between teams to promote cutting-edge research.
    • Innovative Biomarker Strategies: Her strategic planning at Novartis and Roche Pharmaceuticals resulted in the establishment of innovative approaches to biomarkers, enhancing their integration into clinical trials and therapeutic development.
    • Promoting Academic Collaborations: Carolina remains dedicated to fostering academic collaborations that bridge scientific discoveries with clinical applications, ensuring that the latest research informs practice in personalized healthcare.

    Carolina Haefliger continues to be a leading light in the realm of clinical genetics and translational medicine, inspiring colleagues and aspiring medical professionals alike. Her unwavering focus on personalized healthcare and advanced study of biomarkers ensures her contributions will resonate through the medical community for years to come.

    Related Questions

    How did Carolina Haefliger develop her expertise in clinical genetics and epigenetics?
    What are some of the most significant contributions Carolina Haefliger has made in the field of oncology and personalized healthcare?
    How does Carolina's role as a Board Observer at Altis Labs influence her work in translational medicine?
    What strategies has Carolina Haefliger employed to foster academic collaborations in her career?
    Can Carolina Haefliger share insights about her experience at major pharmaceutical companies like AstraZeneca and Novartis?
    C
    Add to my network